CYP2C83 polymorphism and donor age are associated with allograft dysfunction in kidney transplant recipients treated with calcineurin inhibitors

Literals

ou:urlScopus
- https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84877860571&origin=inward
bibo:issn
- 0091-2700
ou:eid
- 2-s2.0-84877860571
bibo:eissn
- 1552-4604
dcterms:creator
- Gervasini G.
dcterms:contributor
- Gervasini G.; Garcia M.; Macias R.M.; Benitez J.; Caravaca F.; Cubero J.J.
fabio:hasPublicationYear
- 2013
ou:bibtex
- @article{PMID:23426640, title = {CYP2C8*3 polymorphism and donor age are associated with allograft dysfunction in kidney transplant recipients treated with calcineurin inhibitors.}, author = {Gervasini G and Garcia M and Macias RM and Benitez J and Caravaca F and Cubero JJ}, doi = {10.1002/jcph.15}, journal = {Journal of clinical pharmacology}, month = {04}, year = {2013} }
vivo:identifier
- 2013-226
bibo:doi
- 10.1002/jcph.15
bibo:page_range
- 427-434
dcterms:publisher
- Journal of Clinical Pharmacology
ou:tipoPublicacion
- Article
dcterms:title
- CYP2C83 polymorphism and donor age are associated with allograft dysfunction in kidney transplant recipients treated with calcineurin inhibitors
vcard:url
- https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84877860571&origin=inward
ou:urlOrcid
- http://europepmc.org/abstract/med/23426640
ou:vecesCitado
- 19
bibo:volume
- 53